Eli Lilly and Co (LLY) reports a 45% revenue increase, driven by key products and strategic advancements in diabetes and ...

Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...

Cigna (NYSE:CI) on Friday announced plans to launch a new specialized GLP-1 pharmacy called ENGUIDE from next month, as the ...

Q1 2025 Earnings Call Transcript April 30, 2025 Operator: Good afternoon, thank you for attending today’s Teladoc Health ...

Eli Lilly stock fell more than 5% after the release of its first-quarter 2025 earnings, which, even though they exceeded overall revenue and profit estimates, showed that sales of its anti-obesity ...